Yun Kang, Danying Liao, Wei Xie, Lin Liu, Yinqiang Zhang, Heng Mei. "Lipo-MIT-based bridging therapy enables effective CAR-T treatment in high-risk relapsed or refractory B-cell lymphoma." Blood, 2025. doi:10.1182/blood-2025-5935